# EDGAR Filing Document

**Accession Number:** 0001861107
**File Stem:** 0001193125-25-334657
**Filing Date:** 2025-12
**Character Count:** 7090
**Document Hash:** e2af9dbbd5aa4c8b03f5835fed9a4013
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-334657.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0001193125-25-334657

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251120

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251229

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Blumberg Scott
- **CENTRAL INDEX KEY:** 0002035786

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42364
- **FILM NUMBER:** 251607735

**MAIL ADDRESS:**
- **STREET 1:** C/O CERIBELL, INC.
- **STREET 2:** 360 N. PASTORIA AVENUE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ceribell, Inc.
- **CENTRAL INDEX KEY:** 0001861107
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 471785452
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 360 N. PASTORIA AVENUE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085
- **BUSINESS PHONE:** (800) 436-0826

**MAIL ADDRESS:**
- **STREET 1:** 360 N. PASTORIA AVENUE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Blumberg Scott<br><sub>(Last) (First) (Middle)</sub><br>C/O CERIBELL, INC.<br>360 N. PASTORIA AVENUE<br><sub>(Street)</sub><br>SUNNYVALE, CA 94085<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-11-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Ceribell, Inc. [ CBLL ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-11-20 |  | F |  | 687 | D | $13.64 | 118842<sup>(1)</sup> | D |  |
| Common Stock | 2025-12-22 |  | M<sup>(2)</sup> |  | 4752 | A | $3.65 | 123594 | D |  |
| Common Stock | 2025-12-22 |  | S<sup>(2)</sup> |  | 4752 | D | $21 | 118842 | D |  |
| Common Stock | 2025-12-22 |  | M<sup>(2)</sup> |  | 11529 | A | $3.65 | 130371 | D |  |
| Common Stock | 2025-12-22 |  | S<sup>(2)</sup> |  | 11529 | D | $21 | 118842 | D |  |
| Common Stock | 2025-12-22 |  | M<sup>(2)</sup> |  | 19719 | A | $4.7 | 138561 | D |  |
| Common Stock | 2025-12-22 |  | S<sup>(2)</sup> |  | 19719 | D | $21 | 118842 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | $3.65 | 2025-12-22 |  | M<sup>(2)</sup> |  |  | 4752 | <sup>(3)</sup> | 2031-06-10 | Common Stock | 4752 | $0 | 0 | D |  |
| Stock Option (Right to Buy) | $3.65 | 2025-12-22 |  | M<sup>(2)</sup> |  |  | 11529 | <sup>(3)</sup> | 2031-12-02 | Common Stock | 11529 | $0 | 0 | D |  |
| Stock Option (Right to Buy) | $4.7 | 2025-12-22 |  | M<sup>(2)</sup> |  |  | 19719 | <sup>(4)</sup> | 2033-02-16 | Common Stock | 19719 | $0 | 6869 | D |  |

---

### Footnotes:

(1) Includes 155 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025.

(2) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

(3) The stock option is fully vested and currently exercisable.

(4) The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

**Signature:** /s/ Louisa Daniels, Attorney-in-Fact for Scott Blumberg  
**Date:** 2025-12-29

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**